Steven Paul, Director at SAGE Therapeutics, holds 593.11K shares in SAGE Therapeutics (Ticker: SAGE), holds ― shares in Voyager Therapeutics (Ticker: VYGR), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX).
What is the percentage of profitable transactions made by Steven Paul?
The percentage of profitable transactions made by Steven Paul is 80%.
What is the average return per transaction made by Steven Paul?
The average return per transaction made by Steven Paul is 130.60%.
What stocks does Steven Paul hold?
Steven Paul holds: SAGE, VYGR, KRTX, ALNY, SIAL, LLY stocks.
What was Steven Paul’s latest transaction?
Steven Paul latest transaction was an Uninformative Buy of $190.80.
What was Steven Paul's most profitable transaction?
Steven Paul’s most profitable transaction was an Informative Buy of KRTX stock on July 1, 2019. The return on the trade was 406.90%.
What is Steven Paul's role in SAGE Therapeutics?
Steven Paul's role in SAGE Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.